Sentences with phrase «generic drug maker»

JERUSALEM — Israeli generic drug maker Teva Pharmaceutical Industries on Thursday said first - quarter earnings surged over 80 percent and raised its outlook for the rest of the year, citing progress in an aggressive restructuring plan.

JERUSALEM (AP)-- Israeli generic drug maker Teva Pharmaceutical Industries on Thursday said first - quarter earnings surged over 80 percent and raised...

After graduating with degrees in psychology and social work — both of which Witt says are extremely beneficial in real estate — she worked as a marketing coordinator for generic drug maker Pharmascience, organizing activities for 40 sales reps.

BERLIN German healthcare group Fresenius SE said it had decided to pull out of its planned acquisition of Akorn after it found data integrity breaches at the U.S. generic drug maker.

Rajiv Malik, president and executive director at EpiPen maker Mylan (essentially the company's number two exec), has been named in a wide - ranging civil suit alleging drug price collusion by numerous prominent generic drug makers.

After generic drug maker Actavis bought Allergan last year, it took the name of the specialty pharmaceutical company; the reinvented Allergan then turned around and sold its legacy generic business to Teva Pharmaceutical Industries (TEVA) in July.

The stock plunged 35 percent after it said that it would appeal a U.S. court ruling that generic drug maker Dr Reddy's had not infringed its patents.

The chairman, CEO and sole owner of Canada's biggest generic drug maker is the only person on our list who can claim the title of astrophysicist (he has a degree from MIT).

In December, attorneys general in 20 states accused several generic drug makers, including two of the biggest — Teva Pharmaceuticals and Mylan — of engaging in a price - fixing scheme in which executives coordinated at informal gatherings and through phone calls and text messages.

In July, generic drug maker Perrigo Co. agreed to buy Ireland's Elan Corp..

Since 2007, drug shortages in the United States have been growing in number, driven by the consolidation of generic drug makers, a tendency by hospitals and wholesalers to order medicines on demand rather than stockpile supplies, and a spate of manufacturing problems ranging from mould contamination to the presence of glass particles in injected drugs.

Then, the U.S. Supreme Court's decision in Pliva v. Mensing limited generic drug makers» pharmaceutical injury liability.

** German healthcare group Fresenius SE said it had decided to pull out of its planned acquisition of Akorn after it found data integrity breaches at the U.S. generic drug maker.

Patient advocates, generic drug makers, and even some biotech investors promptly rebuked Allergan after the arrangement was announced Friday, arguing that the IP gymnastics will only worsen biopharma's miserable reputation on drug pricing issues.

That's an even rarer feat for a generic drug maker such as Mylan, which makes most of its revenue not on brand - name drugs, but on cheaper, equivalent versions of other companies» branded medications.

The generic drug maker has hired Morgan Stanley to review available options, including an acquisition or sale of the company.

Generally understood as a provision permitting companies to test or experiment with patented inventions prior to an FDA submission - such as a generic drug maker prior to submission of an ANDA - the provision's scope has expanded over the years.

The analyst their cites the generic drug maker «s diversified business model and its ability to grow profit and sales over the next several years.

«A civil war has broken out among the most powerful players in the pharmaceutical industry — including brand - name and generic drug makers, and even your local pharmacists — with each blaming others for the rising price of medicine.»

Similarly, in 2011 in the EU there were 13 settlements limiting generic entry and involving payment to a generic drug maker.

Generic drug makers may be the «new defensive» plays in modern times, but anyone who has owned either generic drug companies or «big pharma» drug companies over the last 10 to 12 years can affirm that this defensive stock stigma is not as true as the classical business models used to indicate.

A generic drug maker who wishes to obtain consent from Health Canada to market a drug based on the same active ingredient (called a Notice of Compliance or... [more]

The generic drug maker («generic») may address such listed patents by accepting that its product will not receive an NOC until expiry of a listed patent, or may assert that its product would not infringe the claims of such listed patent or may challenge the validity of a listed patent.

A generic drug maker who wishes to obtain consent from Health Canada to market a drug based on the same active ingredient (called a Notice of Compliance or NOC) must address the applicable patents on the Patent List.

He did however dismiss the claims against Mylan Inc., the generic drug maker.

While pharmaceutical giant Pfizer is trying to get the Supreme Court of Canada to take a second look at its recent judgment voiding its patent on Viagra, it's trying to use the same decision to quash a case in the Federal Court involving another generic drug maker.

Now, the defendant is appealing to our nation's highest court, contending that «scores» of courts, both state and federal, had turned down the 1st Circuit's claim that generic drug makers can be liable under the laws of a state for refusing to cease the sale of products that have federal government approval.

Under the law, generic drug makers are not allowed to change the labeling designated by the makers of brand name drugs.

The generic drug maker also admitted to improperly storing drug samples that were to be tested, delaying a voluntary recall of epilepsy drug Gabapentin (the recall would go on to involve over 73 million pills), making false statements to the FDA, and continuing to sell a drug that failed purity testing.

Generic drug makers are always trying to find a way through to market their products before patents expire.